Sumitomo Mitsui Trust Group
REGN icon

Sumitomo Mitsui Trust Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$162M Buy
308,185
+4,516
+1% +$2.37M 0.1% 197
2025
Q1
$193M Buy
303,669
+1,053
+0.3% +$668K 0.14% 150
2024
Q4
$216M Buy
302,616
+1,108
+0.4% +$789K 0.15% 138
2024
Q3
$317M Buy
301,508
+3,866
+1% +$4.06M 0.22% 92
2024
Q2
$313M Sell
297,642
-21,406
-7% -$22.5M 0.23% 84
2024
Q1
$307M Sell
319,048
-301
-0.1% -$290K 0.21% 95
2023
Q4
$280M Sell
319,349
-8,972
-3% -$7.88M 0.21% 105
2023
Q3
$270M Sell
328,321
-5,080
-2% -$4.18M 0.22% 94
2023
Q2
$240M Sell
333,401
-39,737
-11% -$28.6M 0.19% 118
2023
Q1
$307M Sell
373,138
-6,471
-2% -$5.32M 0.23% 96
2022
Q4
$274M Sell
379,609
-11,541
-3% -$8.33M 0.22% 105
2022
Q3
$269M Sell
391,150
-8,184
-2% -$5.64M 0.22% 105
2022
Q2
$236M Sell
399,334
-7,340
-2% -$4.34M 0.18% 118
2022
Q1
$284M Sell
406,674
-25,541
-6% -$17.8M 0.19% 115
2021
Q4
$273M Sell
432,215
-37,054
-8% -$23.4M 0.17% 130
2021
Q3
$284M Sell
469,269
-82,083
-15% -$49.7M 0.18% 123
2021
Q2
$308M Buy
551,352
+55,497
+11% +$31M 0.18% 126
2021
Q1
$235M Buy
495,855
+46,254
+10% +$21.9M 0.15% 162
2020
Q4
$217M Sell
449,601
-10,971
-2% -$5.3M 0.14% 163
2020
Q3
$258M Sell
460,572
-21,435
-4% -$12M 0.17% 131
2020
Q2
$301M Buy
482,007
+80,867
+20% +$50.4M 0.21% 103
2020
Q1
$196M Sell
401,140
-64,683
-14% -$31.6M 0.17% 137
2019
Q4
$175M Sell
465,823
-8,682
-2% -$3.26M 0.14% 167
2019
Q3
$132M Buy
474,505
+36,796
+8% +$10.2M 0.11% 209
2019
Q2
$137M Buy
437,709
+110,242
+34% +$34.5M 0.12% 194
2019
Q1
$134M Buy
327,467
+22,752
+7% +$9.34M 0.12% 182
2018
Q4
$110M Buy
304,715
+51,513
+20% +$18.7M 0.12% 188
2018
Q3
$102M Buy
253,202
+6,047
+2% +$2.44M 0.11% 208
2018
Q2
$85.3M Buy
247,155
+23,567
+11% +$8.13M 0.1% 222
2018
Q1
$77M Buy
223,588
+3,812
+2% +$1.31M 0.1% 226
2017
Q4
$82.6M Buy
219,776
+2,867
+1% +$1.08M 0.11% 210
2017
Q3
$97M Sell
216,909
-3,131
-1% -$1.4M 0.14% 174
2017
Q2
$108M Buy
220,040
+3,258
+2% +$1.6M 0.16% 152
2017
Q1
$84M Buy
216,782
+780
+0.4% +$302K 0.13% 186
2016
Q4
$79.3M Buy
216,002
+637
+0.3% +$234K 0.13% 186
2016
Q3
$86.6M Buy
215,365
+387
+0.2% +$156K 0.14% 169
2016
Q2
$75.1M Buy
214,978
+757
+0.4% +$264K 0.13% 192
2016
Q1
$77.2M Buy
214,221
+8,770
+4% +$3.16M 0.14% 170
2015
Q4
$113M Sell
205,451
-1,717
-0.8% -$941K 0.2% 117
2015
Q3
$96.4M Buy
207,168
+3,272
+2% +$1.52M 0.19% 127
2015
Q2
$104M Sell
203,896
-12,534
-6% -$6.39M 0.19% 131
2015
Q1
$97.7M Buy
216,430
+28,461
+15% +$12.8M 0.18% 133
2014
Q4
$76.8M Sell
187,969
-2,110
-1% -$862K 0.15% 163
2014
Q3
$68.5M Sell
190,079
-158
-0.1% -$57K 0.14% 178
2014
Q2
$53.7M Sell
190,237
-5,915
-3% -$1.67M 0.11% 222
2014
Q1
$58.9M Buy
196,152
+1,985
+1% +$596K 0.12% 196
2013
Q4
$54M Sell
194,167
-8,177
-4% -$2.27M 0.11% 210
2013
Q3
$63.3M Sell
202,344
-1,400
-0.7% -$438K 0.14% 173
2013
Q2
$45.8M Buy
+203,744
New +$45.8M 0.1% 229